Lloyd Mencinger, Aqua Medical - Vapor-Based Endoscopic Ablation Therapy | LSI Europe '24

Aqua Medical has developed a through-the-endoscope vapor ablation platform to change the course of metabolic disease, including type 2 diabetes, through duodenal ablation with an ultrashort (30-minute), trans-oral, outpatient procedure.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Lloyd Mencinger
Lloyd Mencinger
President & CEO, Aqua Medical